Boston Medical Center
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Boston Medical Center
FDA Releases COVID-19 Test Performance Data
The data compares the sensitivity of almost 200 diagnostics against a standardized set of samples.
Tech Transfer Roundup: Roivant Taps Research Labs For New Gene Therapies
In tandem with Roivant, Cincinnati Children’s launches spinout Aruvant focused on hematologic disorders and separately teams with BridgeBio on genetic disease therapies. Roivant spinout Axovant licenses gene therapy candidates from University of Massachusetts.
Advanced Wound Care: A Future Built On Innovation
The advanced wound care market is attracting an increasing number of competitors and investors seeking a stake in this high-need, high-growth space. But although the number of innovative wound care products is on the rise, this is also a highly diverse market, with some striking differences among various regions of the world in terms of product adoption and standard wound care practices.
Radial Approach to Angioplasty Gaining Momentum
If technology changes and clinical outcomes assert their influence over standard protocols, an increasing number of Americans patients will undergo coronary angioplasty through the radial artery in their wrist, not the femoral artery in their groin. As studies are beginning to portray more clearly, those patients are likely to be more comfortable postprocedure, exhibit less bleeding, and recover more quickly than patients treated treated with the traditional femoral approach.
- Academic and Research Institutions
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.